Minnie Mildwoff
Direttore/Membro del Consiglio presso STRM.Bio, Inc.
Profilo
Minnie Mildwoff is currently working as a Director at STRM.Bio, Inc. and also holds a position as Global Therapeutic Area Lead at Novartis Corp.
She completed her undergraduate degree at the University of California, Los Angeles, and her graduate degrees at Massachusetts College of Pharmacy & Health Science and Suffolk University Law School.
Posizioni attive di Minnie Mildwoff
| Società | Posizione | Inizio |
|---|---|---|
STRM.Bio, Inc.
 STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Direttore/Membro del Consiglio | 24/07/2023 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formazione di Minnie Mildwoff
| Suffolk University Law School | Graduate Degree |
| Massachusetts College of Pharmacy & Health Science | Graduate Degree |
| University of California, Los Angeles | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
STRM.Bio, Inc.
STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Minnie Mildwoff
